Genomic liquid biopsy company leveraging cutting-edge data analytics to transform cancer care. UriSeq, our proprietary urine sequencing platform, enables actionable insights that are otherwise unattainable in today's clinical cancer management. Our innovative solutions bring unprecedented clarity to clinical decision making by both outperforming current technology and introducing new paradigms to better detect, surveil, and treat cancer. Our Mission: Transforming cancer care through clear and actionable insights.